Cardiovascular biology of the A3 adenosine receptor

A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics

Volumn , Issue , 2010, Pages 189-208

  Headrick, John P ^a   Peart, Jason N ^a   Wan, Tina C ^b   Kwok, Wai Meng ^b   Auchampach, John A ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

angiogenesis; Cardiovascular system; Gi protein coupled A3 adenosine receptor; ischemia; mast cells; reperfusion; vascular tone

Indexed keywords

EID: 84900067616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3144-0_10     Document Type: Chapter

References (142)

1. Angello DA, Headrick JP, Coddington NM, Berne RM (1991) Adenosine antagonism decreases metabolic but not functional recovery from ischemia. Am J Physiol 260 1 Pt 2:H193-H200
2. 3 receptor involvement. Cardiovasc Res 28(7): 1049-1056
3. Auchampach JA, Bolli R (1999) Adenosine receptor subtypes in the heart: Therapeutic opportunities and challenges. Am J Physiol 276 (3) Pt 2:H1113-H1116
4. 2B receptor. Mol Pharmacol 52(5):846-860
5. 6-(3-iodobenzyl)adenosine-5¢-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80(6):800-809
6. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285(2):H607-H613
7. Belardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32(1):73-97
8. Belardinelli L, Shryock JC, Wand SD, Srinivas M (1995) Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB 9(5):359-365
9. 2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284(3):1066-1073
10. Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204(Feb):317-322
11. 3 adenosine receptor. Circ Res 91(2):165-172
12. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B (2008) Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295(4):H1580-H1586
13. 3 receptor-mediated preconditioning in rat ventricle strips. Exp Physiol 90(5):747-754
14. 3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovasc Res 36(1):52-59
15. 3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am J Physiol Heart Circ Physiol 281(4):H1751-H1758
16. Chaudary N, Naydenova Z, Shuralyova I, Coe IR (2004) The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1. J Pharmacol Exp Ther 310(3):1190-1198
17. 3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84(8):1848-1855
18. 1 adenosine receptor activation promotes angiogenesis and release of VEGF from mono-cytes. Circ Res 101(11):1130-1138
19. 3 adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol 283(4):H1562-H1568
20. 3 receptor by Akt-dependent and-independent pathways. J Pharmacol Exp Ther 314(2):762-769
21. 3 receptor activation. Eur J Pharmacol 441(3):165-172
22. DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Adenosine: electrophysio-logic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68(6):1254-1263
23. DiMarco JP, Sellers TD, Belardinelli L (1984) Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for re-entry within the upperportion of the atrioventricular node. J Am Coll Cardiol 3(6):1551-1555
24. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinmman MM, Govier WC (1990) Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med 113(2):104-110
25. Dobson JG (1978) Reduction by adenosine of the isoproterenol-induced increase in cyclic 3', 5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res 43(5):785-792
26. 3 receptor. FASEB 12(15):1785-1792
27. Drury AN, Szent-Györgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68(3):213-237
28. Duncker DJ, Bache RJ (2008) Regulation of coronary blood flow during exercise. Physiol Rev 88(3):1009-1086
29. Dusseau JW, Hutchins PM, Malbasa DS (1986) Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 59(2):163-170
30. Ebrahim Z, Yellon DM, Baxter GF (2007) Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp Gerontol 42(8):807-814
31. 2B adenosine receptors. Circulation 115(12):1581-1590
32. Ely SW, Berne RM (1992) Protective effects of adenosine in myocardial ischemia. Circulation 85(3):893-904
33. 2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96(4):1979-1986
34. 3 adenosine receptors. Circ Res 92(5):485-492
35. Flood A, Headrick JP (2001) Functional characterization of coronary vascular adenosine receptors in the mouse. Br J Pharmacol 133(7):1063-1072
36. Fralix TA, Murphy E, London RE, Steenbergen C (1993) Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis. Am J Physiol 264(4 Pt 1):C986-C994
37. Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, Karmazyn M (2005) Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312(1):27-34
38. Gardner NM, Yates L, Broadley KJ (2004) Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in guinea-pig atria and papillary muscles. J Cardiovasc Pharmacol 43(3):358-368
39. 3 adenosine receptor. J Pharmacol Exp Ther 319(3):1200-1210
40. Gerlach E, Deuticke B, Driesbach RH (1963) Der nucleotid-Abbau im Herzmuskel bei Sauerstoffmangel und seine mogliche Bedeutung fur die Coronardurchblutung. Die Naturwissenschaften 50(6):228-229
41. Germack R, Dickenson JM (2004) Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes. Br J Pharmacol 141(2):329-339
42. 3 receptors in newborn rat cardiomyocytes. J Mol Cell Cardiol 37(5):989-999
43. 3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117(1):123-140
44. 3 and bradykinin B2 receptor activation. Circ Res 81(3):415-422
45. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, Belardinelli L (1999) Adenosine receptor activation induces vascular endothe-lial growth factor in human retinal endothelial cells. Circ Res 85(8):699-706
46. AT P channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285(3):H921-H930
47. 3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol 33(4):825-830
48. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61(3):372-385
49. 3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovasc Res 53(1):147-155
50. Hausenloy D, Wynne A, Duchen M, Yellon D (2004) Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109(14):1714-1717
51. 1 adenosine receptor overexpression. J Physiol 549(Pt 3):823-833
52. 2A receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther 291(2):655-664
53. Headrick JP, Berne RM (1990) Endothelium-dependent and-independent relaxations to adenosine in guinea pig aorta. Am J Physiol 259(1 Pt 2):H62-H67
54. Hinschen AK, Rose'Meyer RB, Headrick JP (2003). Adenosine receptor subtypes mediating coronary vasodilation in rat hearts. J Cardiovasc Pharmacol 41(1):73-80
55. 3 receptor activation in the normal and hypertrophied heart. Interact Cardiovasc Thorac Surg 6(3):363-368
56. Hosey MM, McMahon KK, Green RD (1984) Inhibitory adenosine receptors in the heart: characterization by ligand binding studies and effects on beta-adrenergic receptor stimulated adenylyl cyclase and membrane protein phosphorylation. J Mol Cell Cardiol 16(10):931-942
57. Hussain T, Mustafa SJ (1995) Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1, 3-dipropylxanthine in coronary smooth muscle. Circ Res 77(1):194-198
58. Isenberg G, Belardinelli L (1984) Ionic basis for the antagonism between adenosine and isoprot-erenol on isolated mammalian ventricular myocytes. Circ Res 55(3):309-325
59. 3 receptor mediated coronary vasodilation in the rat heart: changes that occur with maturation. Mech Ageing Dev 127(3):264-273
60. 3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100(11):2849-2857
61. 3 adenosine receptor activation attenuates neutrophil function and neutrophilmediated reperfu-sion injury. Am J Physiol Heart Circ Physiol 277(5 Pt 2): H1895-H1905.
62. 2B receptors. Br J Pharmacol 126(8):1796-1800
63. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278(4):H1218-H1224
64. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, Zhao ZQ, Guyton RA, Headrick JP, Vinten-Johansen J (2005) Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67(1):124-133
65. Kodani E, Bolli R, Tang XL, Auchampach JA (2001a) Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor. Basic Res Cardiol 96(5):487-496
66. 3 receptors. Am J Physiol Heart Circ Physiol 281(2):H959-H968
67. 2B-depdent signalling during early reperfusion. J Mol Cell Cardiol 43(3):262-271
68. + channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch 407(3):264-274
69. Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F, Hirsch E, Wymann MP (2002) Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 16(3):441-451
70. LaMonica DA, Frohloff N, Dobson JG (1985) Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 248(5 Pt 2):H737-H744
71. 3-receptor agonists IB-MECA and Cl-IB-MECA. Am J Physiol 276 6 Pt 2:H2076-H2084
72. Lee JE, Bokoch G, Liang BT (2001) A novel cardioprotective role of RhoA: new signaling mechanism for adenosine. FASEB J 15(11):1886-1894
73. 2A receptor agonists and endotoxin. Am J Pathol 160(6):2231-2244
74. 3 receptors: pharmacological properties, species differences, and receptor functions. Trends Pharmacol Sci 15(8):298-306
75. 3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation 118(17):1713-1721
76. Maczewski M, Beresewicz A (1998) The role of adenosine and ATP-sensitive potassium channels in the protection afforded by ischemic preconditioning against the post-ischemic endothelial dysfunction in guinea-pig hearts. J Mol Cell Cardiol 30(9):1735-1747
77. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 283(4):H1307-H1313
78. Maddock HL, Broadley KJ, Bril A, Khandoudi N (2002b) Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO. J Pharm Pharmacol 54(6):859-867
79. 3 receptor agonist, IB-MECA. Eur J Pharmacol 477(3):235-245
80. Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V (1994) Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201(2): 508-515
81. Marinovic J, Ljubkovic M, Stadnicka A, Bosnjak ZJ, Bienengraeber M (2008) Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mito-chondrial connection. Am J Physiol Heart Circ Physiol 294(3):H1317-H1325
82. Meininger CJ, Zetter BR (1992) Mast cells and angiogenesis. Semin Cancer Biol 3(2):73-79
83. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA (2007) Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 72(2):395-406
84. Miki T, Miura T, Tsuchida A, Nakano A, Hasegawa T, Fukuma T, Shimamoto K (2000) Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 102(4):458-463
85. Miyazaki K, Komatsu S, Ikebe M, Fenton RA, Dobson JG Jr (2004) Protein kinase Cε and the antiadrenergic action of adenosine in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 287(4): H1721-H1729.
86. 2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 293(4):H2523-H2529
87. 2A adenosine receptor induction. Biochem J 391(Pt 3):575-580
88. Norton GR, Woodiwis AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG, Meyer TE (1999) Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2A receptor activation in rat heart. Am J Physiol 276(2 Pt 2):H341-H349
89. 6-(3- iodobenzyl)-adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther 318(1):124-131.
90. Parsons M, Young L, Lee JE, Jacobson KA, Liang BT (2000) Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB 14(10):1423-1431
91. Peart J, Flood A, Linden J, Matherne GP, Headrick JP (2002) Adenosine-mediated cardioprotec-tion in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol 39(1):117-129
92. Peart J, Willems L, Headrick JP (2003) Receptor and non-receptor- dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol 284(2):H519-H527
93. Peart JN, Headrick JP (2008) Sustained cardioprotection: exploring unconventional modalities. Vascular Pharmacol 49(2-3):63-70
94. 2b receptor cascade. Cardiovasc Res 70(2):308-314
95. 3 receptor activation modulates the capillary endothelial glycocalyx. Circ Res 94(1):77-82
96. 2A receptor activation. Am J Physiol Heart Circ Physiol 284(6):H2360-H2367
97. Przyklenk K, Maynard M, Darling CE, Whittaker P (2008) Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 51(14):1393-1398
98. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268(23):16887-16890
99. 2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta. Br J Pharmacol 100(3):576-580
100. Rubio R, Ceballos G (2003) Sole activation of three luminal adenosine receptor subtypes in different parts of coronary vasculature. Am J Physiol 284(1):H204-H214
101. 3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 217(1-2):143-152
102. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275(6):4429-4434
103. Sato A, Terata K, Miura H, Toyama K, Loberiza FR Jr, Hatoum OA, Saito T, Sakuma I, Gutterman DD (2005) Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 288(4):H1633-H1640
104. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, Latchman D (2001) Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104(3):253-256
105. Schrader J, Baumann G, Gerlach E (1977) Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch 372(1):29-35
106. Schulman D, Latchman DS, Yellon DM (2001) Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 281(4):H1630-H1636
107. Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15(9):813-827
108. 3 adenosine receptor. Circ Res 78(4):627-634
109. 3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. Am J Physiol Heart Circ Physiol 288(6):H2792-H2801
110. Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2-10
111. Song Y, Srinivas M, Belardinelli L (1994) The effects of adenosine on isoproterenol-induced outward currents in cardiac ventricular myocytes. Drug Dev Res 31(4):324 (Abstract)
112. Song Y, Belardinelli L (1996) Electrophysiological and functional effects of adenosine on ventricular myocytes of various mammalian species. Am J Physiol 271(4 Pt 1):C1233-C1243
113. St Hilaire C, Carroll SH, Chen H, Ravid K (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol 218(1):35-44
114. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP (1996) Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37(11):2165-2176
115. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88(5):520-528
116. 3 receptors augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Heart Circ Physiol 282(6):H2183-H2189
117. Tang Z, Diamond MA, Chen JM, Holly TA, Bonow RO, Dasgupta A, Hyslop T, Purzycki A, Wagner J, McNamara DM, Kukulski T, Wos S, Velazquez EJ, Ardlie K, Feldman AM (2007) Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy. Clin Pharmacol Ther 82(4):435-440
118. 1 adenosine receptors in regulation of vascular tone. Am J Physiol Heart Circ Physiol 288(3):H1411-H1416
119. AT P channels. Am J Physiol 277(1 Pt 2):H228-H235
120. 3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction. Ann Thorac Surg 67(6):1732-1737
121. 2A receptors in isolated murine hearts. Am J Physiol Heart Circ Physiol 290(1):H348-H356
122. 3 receptors on mast cells. J Clin Invest 105(3):361-367
123. Tosaki A, Engelman DT, Engelman RM, Das DK (1996) The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31(4):526-536
124. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc Res 33(2):410-415
125. AT P channel activation. Cardiovasc Res 40(1):138-145
126. 3 receptors reduce ischemic myocardial injury. Am J Physiol Heart Circ Physiol 285(6): H2780-H2787
127. 3 adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol 74(3):685-696
128. 3 adenosine receptor agonist, in healthy young men. Int J Clin Pharmacol Ther Toxicol 42(10):534-542
129. Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, Nakamura M, Velez D, Guyton RA (1999) Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68(5):1942-1948
130. 3 adenosine receptor agonist CP-532, 903 [N6-(2, 5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 324(1):234-243
131. Wang J, Whitt SP, Rubin LJ, Huxley VH (2005) Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes. Microcirculation 12(4):313-326
132. Willems L, Headrick JP (2007) Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium. Pflugers Arch 453(4):433-441
133. Woodiwiss AJ, Honeyman TW, Fenton RA, Dobson LG (1999) Adenosine A2A-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and-dependent mechanisms. Am J Physiol 276(5 Pt 2):H1434-H1441
134. 1 and bradykinin B2 receptors gene knockout mice. Circulation 118(14 Suppl):S32-S37
135. Zatta AJ, Matherne GP, Headrick JP (2006) Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart. Life Sci 78(21):2426-2437
136. AT P channel. J Mol Cell Cardiol 34(3):263-277
137. 3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in camp. Microvasc Res 54(3):243-252
138. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500(3):280-290
139. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579-H588
140. 3 receptor. J Immunol 171(1): 338-345
141. Ziada AM, Hudlicka O, Tyler KR, Wright AJ (1984) The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovas Res 18(12): 724-732
142. 2+ release in rat heart. Cardiovasc Res 50(1):56-64.